The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 49-59 , January 2003

Use of two recipient lists for adults requiring heart transplantation

Presented in part at the annual meeting of the International Society of Heart and Lung Transplantation, Osaka, Japan, April 2000.

Received 24 January 2002 ,Revised 4 June 2002 ,Accepted 8 July 2002.

References 

  1. Stevenson LW. When is heart failure a surgical disease?. In:  Rose EA,  Stevenson LW editor. Management of end-stage heart disease. New York: Lippincott-Raven; 1998;p. 129–146
  2. Annual report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: transplant data 1989-1998 [monograph online] 2000 Feb 21 [cited 2001 Jul 8]. Available from: URL: http://www.unos.org/Data/anrpt_main.htm
  3. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management. J Heart Lung Transplant. 1999;18:1065–1070
  4. Borkon AM, Muehlebach GF, Jones PG, Bresnahan DR, Genton RE, Gorton ME, et al.  An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant. 1999;18:668–674
  5. Sweeney MS, Lammermeier DE, Frazier OH, Burnett CM, Haupt HM, Duncan JM. Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg. 1990;50:7–10
  6. Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, et al.  Matching the heart donor and heart transplant recipient: clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13:353–365
  7. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, et al.  24th Bethesda conference: Cardiac transplantation. Task Force 3: recipient guidelines/prioritization. J Am Coll Cardiol. 1993;22:21–31
  8. Laks H, Marelli D, Fazio D, Kobashigawa JA. Expanding the heart donor base. Curr Opin Organ Transplant. 2000;5:134–138
  9. Stein DG, Drinkwater DC, Laks H, Permut LC, Sangwan S, Chait HI, et al.  Cardiac preservation in patients undergoing transplantation: a clinical trial comparing University of Wisconsin solution and Stanford solution. J Thorac Cardiovasc Surg. 1991;102:657–665
  10. Leyh RG, Jahnke AW, Kraatz EG, Sievers HH. Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation. Ann Thorac Surg. 1995;59:1495–1500
  11. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Lung Transplant. 1990;9:587–593
  12. Pflugfelder PW, Thomson D, Singh NR, Menkis AH, McKenzie FN, Kostuk WJ. Cardiac allograft ischemic time: relation to graft survival and cardiac function. Circulation. 1989;80(5 Pt 2):III116–III121
  13. In: Webster's Ninth New Collegiate Dictionary. Springfield (MA): Merriam-Webster; 1990;p. 72
  14. Ong JP, Barnes DS, Younossi ZM, Gramlich T, Yen-Lieberman B, Goormastic M, et al.  Outcome of de novo hepatitis C virus infection in heart transplant recipients. Hepatology. 1999;30:1248–1293
  15. Jeevanandam V, Furukawa S, Prendergast TW, Todd B, Isen HJ, McClurken JB. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996;62:1268–1275
  16. Young JB. Age before beauty: the use of “older” donor hearts for cardiac transplantation. J Heart Lung Transplant. 1999;18:488–491
  17. Marelli D, Laks H, Fazio D, Sadeghi A, Ardehali A, Moriguchi J, et al.  The use of marginal donor hearts. (abstract) J Heart Lung Transplant. 2000;19:76
  18. Tsai FC, Marelli D, Bresson J, Gjerston D, Kerman R, Patel J, et al.  Use of hearts transplanted from donors with atraumatic intracranial bleeds. J Heart Lung Transplant. 2002;21:623–628
  19. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778–786
  20. Costanzo MR, Naftel DC, Pritzker MR, Heilman JK, Boehmer JP, Brozena SC, et al.  Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant. 1998;17:744–753
  21. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al.  Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621–627

☆ *For other members of the Heart Transplant Program, University of California, Los Angeles, see end of article.

☆☆ Address for reprints: Hillel Laks, MD, UCLA School of Medicine, 10833 Le Conte Ave, 62-182 CHS, Box 951741, Los Angeles, CA 90095-1741 (E-mail:Llaks@mednet.ucla.edu).

★ 0022-5223/2003 $30.00+0

PII: S0022-5223(02)73309-6

doi: 10.1067/mtc.2003.62

The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 49-59 , January 2003

Article Tools

* Image Usage & Resolution